Multiple Sclerosis. Old Wine in New Bottles

Carswell R . Pathological Anatomy, Illustrations of the Elementary Forms of Disease. London: Longmans Green & Co 1838.

Charcot JM . Histologic de la sclérose en plaques. Gaz Hôp (Paris) 1868; 41:405–566.

Greenfield JC . Demyelinating diseases. In Greenfield JG Blackwood W McMenemey WH Meyer A Norman RM . eds. Neuropathology. London: Arnold 1958; chap. 7:441–474.

Lumsden CE . The pathology of multiple sclerosis. In Vinken PJ Bruyn GW . eds. Handbook of Clinical Neurology, Vol. 9: Multiple Sclerosis and other Demyelinating Diseases. Amsterdam: North-Holland 1970;217–309.

Charcot JM . Lectures on the Diseases of the Nervous System (trans. Sigerson G ) London: 1st Series 1877, The New Sydenham Society.

Adams CWM . Pathology of multiple sclerosis: Progression of the lesion. Br Med Bull 1977; 33(1): 15–20.

Lumsden CE . The clinical pathology of multiple sclerosis. In McAlpine D Lumsden CE Acheson ED . eds. Multiple Sclerosis: a reappraisal Edinburgh: Livingstone 1965;243–393.

Thomson RHS . Fatty acid metabolism in multiple sclerosis. Biochem Soc Symp 1973; 35:103–111.

Swank RL . Treatment of multiple sclerosis with low-fat diet. Arch Neurol Psychiat (Chicago) 1953; 69:91–103.

Brownell B Hughes T . The distribution of plaques in the cerebrum in multiple sclerosis J Neurol Neurosurg Psychiat 1962; 25:315–320.

Matthews WB . Epilepsy and disseminated sclerosis. Q J Med 1962; 31:141–155.

Bergin JD . Rapidly progressing dementia in disseminated sclerosis. J Neurol Neurosurg Psychiat 1957; 20:285–292.

Oppenheim H . Textbook of Nervous Diseases (trans. Bruce A. N. ). Edinburgh: Foulis 1911.

Andermann F Cosgrove JBR Lloyd-Smith DL Gloor P McNaughton FL . Facial myokymia in multiple sclerosis. Brain 1961; 84:31–44.

Weir AI Hansen S Ballantyne JP . The single fibre electromyographic jitter in multiple sclerosis. J Neurol Neurosurg Psychiat 1979; 42:1146–1150.

Weir AI Hansen S Ballantyne JP . Motor unit potential abnormalities in multiple sclerosis: Further evidence for a peripheral nervous system defect. J Neurol Neurosurg Psychiat 1980; 43:999–1004.

Simpson JA . Conductive velocity of peripheral nerves in human metabolic disorders. Electroenceph Clin Neurophysiol 1962; Suppl. 22:36–43.

Hall JI . Studies on demyelinated peripheral nerves in guinea pigs with experimental allergic neuritis. A histological and electrophysiological study. Brain 1967; 90: 297–312 and 313–332.

Davis FA Becker FO Michael JA Sorensen E . Effect of intravenous sodium bicarbonate, disodium edetate (Na₂EDTA), and hyperventilation on visual and oculomotor signs in multiple sclerosis. J Neurol Neurosurg Psychiat 1970; 33:723–732.

McDonald WI Sears TA . The effects of experimental demyelination on conduction in the central nervous system. Brain 1970; 93:583–598.

McDonald WI . Pathophysiology in multiple sclerosis. Brain, 1974; 97;179–196.

Rasminsky M Sears TA . Internodal conduction in undissected demyelinated nerve fibres. J Physiol (London) 1972; 227:323–350.

Bostock H Sears TA . The internodal axon membrane: Electrical excitability and continuous conduction in segmental demyelination. J Physiol (London) 1978; 280; 273–301.

Kidman AD Dolan L Sippe HJ . Blockade of fast axonal transport by diphtheritic demyelination in the chicken sciatic nerve. J Neurochem 1978; 30:57–61.

Halliday AM McDonald WI . Pathophysiology of demyelinating disease. Br Med Bull 1977; 33(1): 21–27.

Matthews WB Small DG Small M Poutney E . Pattern reversal evoked visual potential in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiat 1977; 40:1009–1114.

Gills JP . Electroretinographic abnormalities and advanced multiple sclerosis. Invest Ophthal 1966; 5:555–559.

Regan D Milner BA Heron JR . Delayed visual perception and delayed visual evoked potentials in the spinal form of multiple sclerosis and in retrobulbar neuritis. Brain 1976; 99:43–66.

Abramsky O Lisak RP Silberberg DH Pleasure DE . Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med 1977; 297:1207–1211.

Traugott U Snyder DS Raine CS . Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann Neurol 1978; 6:13–20.

Kennedy PGE Lisak RP . A search for antibodies against glial cells in the serum and cerebrospinal fluid of patients with multiple sclerosis and Guillain-Barré syndrome. J Neurol Sci 1979; 44:125–133.

Kennedy PGE Lisak RP . Do patients with demyelinating diseases have antibodies against human glial cells in their sera? J Neurol Neurosurg Psychiat 1981; 44:164–167.

Wiśniewski HM . Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull 1977; 33(1) 54–59.

Prineas JW Raine CS . Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology (Minneap) 1976; 26 (6 Pt 2): 29–32.

Wiśniewski HM Bloom BR . Primary demyelination as a nonspecific consequence of cell mediated immune reaction. J Exp Med 1975; 141:346–359.

Lennon VA Carnegie PR . Immunopharmacological disease: A break in tolerance to receptor sites. Lancet 1971; 1:630–633.

Simpson JA . Myasthenia gravis. A new hypothesis. Scott Med J 1960; 5:419–436.

Bornstein MB Appel SH . Tissue culture studies of demyelination. Ann NY Acad Sci 1965; 122:280–286.

Seil FJ . Tissue culture studies of demyelinating disease: A critical review. Ann Neurol., 1977; 2:345–355.

Bornstein MB Crain SM . Functional studies of cultured brain tissues as related to ‘demyelinative’ disorders. Science (New York) 1965, 148: 1242–1244.

Cerf JA Carels G . Multiple sclerosis: Serum factor producing reversible alterations in bioelectric responses. Science (New York) 1966; 152:1066–1068.

Lumsden CE Howard L Aparicio SR Bradbury M . Anti-synaptic antibody in allergic encephalomyelitis II. The synapse-blocking effects in tissue culture of demyelinating sera from experimental allergic encephalomyelitis. Brain Res 1975; 93:283–299.

Simpson JA . Myasthenia. In Bouchier IAD . ed. Seventh Symposium on Advanced Medicine. London: Pitman Medical 1971:141–150.

Knight SC Lance EM Abbosh J Munro A O'Brien J . Intensive immunosuppression in patients with disseminated sclerosis. III Lymphocyte response in vitro. Clin Exp Immunol 1975; 21:23–31.

Paterson PY Harwin SM . Suppression of allergic encephalomyelitis in rats by means of antibrain serum. J Exp Med 1963; 117:755–774.

Brosnan CF Stoner GL Bloom BR Wiśniewsky HM . Studies on demyelination by activated lymphocytes in the rabbit eye. II Antibodydependent cell-mediated demyelination. J Immunol 1977; 118:2103–2110.

Davison AN Cuzner ML . Immunochemistry and biochemistry of myelin. Br Med Bull 1977; 33:(l):60–66.

Henle G Koldovsky U Koldovsky P Henle W Ackermann R Haase G . Multiple sclerosis associated agent: Neutralization of the agent by human sera. Infect Immun 1975; 12:1367–1374.

Dube VE McDuffie FC Burton RC Ilstrup D . Cerebrospinal fluid complement in multiple sclerosis. J Lab Clin Med 1973; 81:530–537.

Johnson RT . The possible viral etiology of multiple sclerosis. In Friedlander WJ . ed. Advances in Neurology, Vol 13, Current Reviews. New York: Raven Press 1975:1–46.

Adams JM Imagawa DT . Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 1962; 111:562–566.

Fraser KB Shirodaria PV Haire M . Enzyme treatment of unfixed cell cultures as a means of determining different specificities of immunoglobulin-M in multiple sclerosis and measles. Med Microbiol Immunol (Berlin) 1974; 160:221–230.

Ross CAC Lenman JAR Rutter C . Infective agents and multiple sclerosis. Br Med J 1965; 1:226–229.

Ross CAC Lenman JAR Melville ID . Virus antibody levels in multiple sclerosis. Br Med J 1969; 3:512–513.

Carp RI Licursi PC Merz PA Merz GS . Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J Exp Med 1972; 136:618–629.

Jersild C Svejgaard A Fog T Ammitzboll T . HL-A antigens and diseases. I multiple sclerosis. Tissue Antigens 1973; 3:243–250.

Henson TE Brody JA Sever JL Dypen ML Cannon J . Measles antibody titres in multiple sclerosis patients, siblings and controls. JAMA 1970; 211:1985–1988.

Bertrams J von Fisenne E Hoher PG Kuwert E . Lack of association between HL-A antigens and measles antibody in MS. Lancet 1973; 2:441.

Lenman JAR Peters TJ . Herpes zoster and multiple sclerosis Br Med J 1969; 2:218–220.

Behan PO Melville ID Durward WF McGeorge AP Behan WMH . Transfer-factor therapy in multiple sclerosis. Lancet 1976; 1:988–990.

Mertin J Meade CJ . Relevance of fatty acids in multiple sclerosis. Br Med Bull 1977; 33(1):67–71.

Swank RL . Multiple sclerosis: Twenty years on low fat diet. Arch Neurol (Chicago) 1970; 23:460–474.

Jersild C Fog T Hansen GS Thomsen M Svejgaard A Dupont B . Histocompatibility determinants in multiple sclerosis with special reference to clinical course. Lancet 1973; 2:1221–1225.

Compston DAS Batchelor JR McDonald WI . Blymphocyte alloantigens associated with multiple sclerosis. Lancet 1976; 2:1261–1265.

Kurdi A Abdalat A Ayesh I . Lymphocyte B alloantigens associated with MS in Arabs and North Europeans Lancet 1975; 1:1123–1125.

Lotfi J Nikbin B Derakhsan I Aghai Z Ala F . Histocompatibility antigens (HLA) in multiple sclerosis in Iran. J Neurol Neurosurg Psychiat 1978; 41:699–701.

Arnason BG Fuller TC Lehrieh JR . Wray SH. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis, J Neurol Sci 1974; 22:419–428.

Poskanzer DC Sever JL Sheridan JL Prenney IB . Multiple sclerosis in the Orkney and Shetland Islands IV. Viral antibody titres and viral injections. J Epidemiol Commun Health 1980; 34:258–264.

Poskanzer DC Terasaki PI Prenney IB Sheridan JL Park MS . Multiple sclerosis in the Orkney and Shetland Islands III. Histocompatibility determinants. J Epidemiol Commun Health 1980; 34:253–257.